ACE2 and respiratory failure: Patients with COVID-19 pneumonia may experience increased sympathetic discharge through respiratory failure, changes in blood gases, immune/inflammatory factors, or angiotensin-converting enzyme (ACE)1/ACE2 imbalance [20, 45, 46].